Kleinerman ES - Search Results

1

Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.

Lafleur EA, Koshkina NV, Stewart J, Jia SF, Worth LL, Duan X, Kleinerman ES. Lafleur EA, et al. Among authors: kleinerman es. Clin Cancer Res. 2004 Dec 1;10(23):8114-9. doi: 10.1158/1078-0432.CCR-04-0353. Clin Cancer Res. 2004. PMID: 15585647

2

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.

Kleinerman ES, Jia SF, Griffin J, Seibel NL, Benjamin RS, Jaffe N. Kleinerman ES, et al. J Clin Oncol. 1992 Aug;10(8):1310-6. doi: 10.1200/JCO.1992.10.8.1310. J Clin Oncol. 1992. PMID: 1634921 Clinical Trial.

3

Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines.

Jia SF, Kleinerman ES. Jia SF, et al. Among authors: kleinerman es. Lymphokine Cytokine Res. 1991 Aug;10(4):281-4. Lymphokine Cytokine Res. 1991. PMID: 1932372

4

Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma.

Kleinerman ES, Snyder JS, Jaffe N. Kleinerman ES, et al. J Clin Oncol. 1991 Feb;9(2):259-67. doi: 10.1200/JCO.1991.9.2.259. J Clin Oncol. 1991. PMID: 1988574

5

Effect of recombinant human interleukin 4 on human monocyte activity.

Hudson MM, Markowitz AB, Gutterman JU, Knowles RD, Snyder JS, Kleinerman ES. Hudson MM, et al. Among authors: kleinerman es. Cancer Res. 1990 Jun 1;50(11):3154-8. Cancer Res. 1990. PMID: 2334911

6

In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators.

Hudson MM, Snyder JS, Jaffe N, Kleinerman ES. Hudson MM, et al. Among authors: kleinerman es. Cancer Res. 1988 Sep 15;48(18):5256-63. Cancer Res. 1988. PMID: 3261632

7

Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation.

Kleinerman ES, Meyers PA, Raymond AK, Gano JB, Jia SF, Jaffe N. Kleinerman ES, et al. J Immunother Emphasis Tumor Immunol. 1995 Apr;17(3):181-93. doi: 10.1097/00002371-199504000-00007. J Immunother Emphasis Tumor Immunol. 1995. PMID: 7613644 Clinical Trial.

8

Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.

Kleinerman ES, Gano JB, Johnston DA, Benjamin RS, Jaffe N. Kleinerman ES, et al. Am J Clin Oncol. 1995 Apr;18(2):93-9. doi: 10.1097/00000421-199504000-00001. Am J Clin Oncol. 1995. PMID: 7900714 Clinical Trial.

9

Osteosarcoma metastatic to the pancreas in young patients.

Glass RJ, Eftekhari F, Kleinerman ES, Jaffe N, Nachman J. Glass RJ, et al. Among authors: kleinerman es. Clin Radiol. 1996 Apr;51(4):293-4. doi: 10.1016/s0009-9260(96)80349-7. Clin Radiol. 1996. PMID: 8617044

10

Altered monocyte chemotactic and activating factor gene expression in human glioblastoma cell lines increased their susceptibility to cytotoxicity.

Asano T, An T, Jia SF, Kleinerman ES. Asano T, et al. Among authors: kleinerman es. J Leukoc Biol. 1996 Jun;59(6):916-24. doi: 10.1002/jlb.59.6.916. J Leukoc Biol. 1996. PMID: 8691078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters